INFO & CONTACTS:  +39 02 2390 1

Pulmonology Unit

Milano
Via Giacomo Venezian, 1 , 20133 Milano MI

Roberto Boffi

Prof. Boffi Roberto

Head

Typology: Clinical Area, Departmental Simple Structure

The most important activity of the unit, aimed at hospitalized patients, is the clinical evaluation of patients with lung and thoracic tumors who are candidates for thoracotomy and/or pulmonary resection surgery, with the goal of assessing the risk of postoperative morbidity and mortality.

The evaluation of respiratory conditions is based on spirometry testing to study static and dynamic lung volumes, as well as the measurement of alveolar-capillary diffusion of carbon monoxide to assess the pulmonary interstitium.

High-risk patients also undergo symptom-limited cardiopulmonary exercise testing aimed at measuring maximal oxygen consumption, determining the anaerobic threshold, cardiac output, and cardiac index.

The S.S.D. also provides postoperative monitoring of pulmonary function and clinical care for patients undergoing pulmonary resection, as well as for patients with other oncological diseases affected by pulmonary and bronchial infectious processes.

Another area of activity concerns the monitoring of pulmonary function in patients undergoing chemotherapy, radiotherapy, and immunotherapy treatments known to have potential pulmonary toxicity.

As for outpatients, the Pulmonology Unit carries out clinical and pulmonary function assessment activities, with particular attention to oncology patients already being treated at the Institute, in order to ensure adequate continuity of care.

Considerable attention is also devoted to diagnostic and therapeutic activities in the field of chronic obstructive pulmonary diseases, bronchial asthma, interstitial lung diseases including pulmonary sarcoidosis, and more generally, pulmonary complications related to cigarette smoking, through a dedicated care pathway.

At the Smoking Cessation Center, outpatient visits are carried out three afternoons a week, by telephone appointment and with a referral form completed by the family physician for a “first pulmonology visit” with the diagnostic query “smoking cessation program.” At this clinic (with more than 6,000 patients treated over the years), both active smokers and passive smokers (that is, all those forced to live in enclosed environments with active smokers) may access the service. Active smokers are given two questionnaires: the first to assess nicotine dependence (the Fagerström test), and the second to determine the level of motivation to undertake a smoking cessation program (the questionnaire used is that of Hospital Mondor in Paris). This allows the patient to be directed toward the most appropriate therapy, whether pharmacological or individual psychological support. After 6 and 12 months, follow-up outpatient evaluations are performed, including pulmonary assessment and measurement of exhaled carbon monoxide.

All active smokers are also provided with telephone counseling support. The objective of the Smoking Damage Center is not only to protect the health of passive smokers and combat, or at least limit as much as possible, the worsening of damage in active smokers, but also to inform users—who are often unaware—about the contents of traditional and electronic cigarettes, their mechanisms of action, and all the consequences associated with this habit, which often becomes automatic and taken for granted among smokers.

For information and appointments for pulmonology visits, respiratory function tests, and access to the Anti-Smoking Center, please call (+39) 02.23901 from 8:30 AM to 4:00 PM, Monday through Friday. A medical prescription is required for access through the National Health Service (SSN).


To book private practice services, please call the telephone booking center (CUP) at (+39) 02.2390 1
 

The Pulmonology Unit can ensure a wide range of instrumental investigations, in particular:

  • Spirometry

  • plethysmography

  • pharmacological bronchodilation test

  • cardiopulmonary exercise test

  • walking test

  • O2 saturation measurement

  • CO measurement

Pre-operative evaluations of candidates for oncological surgery, with particular attention to patients suffering from thoracic cancer. Pulmonology consultations for inpatients at the Institute whose respiratory conditions have become complicated, with the development of dedicated respiratory rehabilitation plans in collaboration with the Institute's physiotherapists. Longitudinal functional evaluation of patients who are candidates for potentially pneumotoxic chemo-immuno-radiotherapy treatments. Continuity of care for patients followed at the Institute suffering from oncological and non-oncological respiratory diseases. Outpatient diagnostic and therapeutic activity in the field of non-oncological respiratory diseases and pulmonary complications related to cigarette smoking, with a dedicated care pathway. Clinical research activity, with particular interest in the following topics: the pharmacogenetics of smoking cessation therapies, the interactions between cigarette smoking and air pollution, the dissemination of smoking cessation techniques through educational pathways, the functional evaluation of pulmonary damage secondary to chemo-radiotherapy through the study of respiratory function at rest and with cardiopulmonary exercise testing, the evaluation of pulmonary functional parameters predictive of postoperative complications and mortality in patients undergoing thoracic surgery, identification of the primary pathogens responsible for hospital-acquired pneumonia in cancer patients and subsequent study of antibiotic resistance.

The Smoking Cessation Centre of the Foundation aims not only to protect the health of passive smokers and to combat the worsening of smoking-related damage in active smokers, but also to inform users—who are often unaware—about the composition of cigarettes, the mechanism of action of the substances they contain, and all the consequences that smoking entails.

Monday to Friday from 8:30 AM to 4:00 PM

Access hours for medical representatives: wednesdays from 3:00 PM

Prof. Boffi Roberto
Head

Dott.ssa Busia Alessandra

Dott.ssa Veronese Chiara

Dott.ssa Munarini Elena

Sig. Marco Savioli, caposala

ELISAH – European Linkage of Initiative from Science to Action in Health (EU4HEALTH)

MIE DIAO: A pharmacological and behavioral intervention aimed at smoking cessation among low socio-economic status Chinese immigrants: a 24-month pilot study

Last update: 12/05/2026

Subscribe to the newsletter

Sign up for our newsletter to stay informed about news, events, and updates from the Institute

Subscribe